UNSPSC 85631308: Replacement of left foot skin with nonautologous tissue substitute, full thickness, external approach

This classification denotes the group of activities that yields a surgical intervention or procedure to replacement of left foot skin with nonautologous tissue substitute, full thickness, external approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0HRNXK3

UNSPSC 85631308 Replacement of left foot skin with nonautologous tissue substitute, full thickness, external approach is a Commodity code with minimal relevance to current state and local procurement activity. The code nominally describes a specific surgical procedure for tissue grafting, yet the recent state and local opportunities tagged under it reflect a systematic mismatch: they solicit medical evaluation services, pharmacy benefit management, occupational health surveillance, surgical center-of-excellence networks, temporary health professional staffing, and youth detention medical care—none of which involve foot skin replacement or autologous tissue procedures. The code appears to be a data-classification artifact rather than an active procurement category; the opportunities are healthcare administration, staffing, and benefit management services that do not align with the code's surgical scope.

The issuing bodies across the six recent opportunities span county health systems (Santa Clara County Health System, Collier County Board of County Commissioners, Harris County Juvenile Probation Department), municipal government (City of Phoenix Retirement Office, City of Long Beach), and state transportation agencies (Washington State Department of Transportation). Opportunities are geographically dispersed across Arizona, California, Florida, and Washington, with response dates spanning September 25, 2026 through April 9, 2026. Given the code–opportunity mismatch, this Commodity code shows no meaningful activity in state and local procurement markets and warrants no pursuit by firms specializing in skin grafting, surgical supplies, or tissue substitutes.